Tracing the Origins of Human Disease: A Phylogenomic Toolkit for Identifying Evolutionary Trade‐Offs

Evolutionary trade-offs, in which adaptations that confer fitness advantages simultaneously create disease vulnerabilities, are widely recognized across human biology. Such trade-offs have traditionally been identified through forward reasoning: investigators with deep knowledge of a particular disease recognize that an associated gene or pathway also serves an adaptive function and propose a trade-off hypothesis on this basis. While productive, this approach is opportunistic and disease-specific. No systematic method exists for working in reverse: starting from a disease and tracing its genetic underpinnings to the adaptive biology under historical selection. Here we present a six-step integrative toolkit for identifying disease-specific evolutionary trade-offs. The toolkit proceeds from (1) curating disease-associated gene sets using publicly available genomic platforms, through (2) profiling expression and pathway involvement, (3) identifying statistically enriched biological processes, (4) mapping genes to their evolutionary origins via phylostratigraphy, (5) linking gene emergence to macroevolutionary innovations, to (6) formulating testable trade-off hypotheses with experimental readouts. We discuss the toolkit's strengths and limitations, including conditions under which it is most and least informative, its relationship to developmental and life-history trade-offs, and the caveats inherent in phylostratigraphic dating and database composition. A cross-domain catalog of established trade-offs illustrates the breadth of trade-off biology across human disease. To demonstrate the toolkit in practice, we apply it to atherosclerosis, showing that its disease-susceptibility gene set is enriched in a lipid-immune integration program whose phylostratigraphic distribution converges temporally with the independently dated origin of the vertebrate endothelium (~540-510 MYA). By connecting present-day disease susceptibilities to historical adaptive benefits through an accessible, reproducible pipeline, this toolkit offers a practical method for human biologists investigating the evolutionary origins of disease vulnerability.